Esteve-Luque, V.; Padró-Miquel, A.; Fanlo-Maresma, M.; Corbella, E.; Corbella, X.; Pintó, X.; Candás-Estébanez, B.
Implication between Genetic Variants from APOA5 and ZPR1 and NAFLD Severity in Patients with Hypertriglyceridemia. Nutrients 2021, 13, 552.
https://doi.org/10.3390/nu13020552
AMA Style
Esteve-Luque V, Padró-Miquel A, Fanlo-Maresma M, Corbella E, Corbella X, Pintó X, Candás-Estébanez B.
Implication between Genetic Variants from APOA5 and ZPR1 and NAFLD Severity in Patients with Hypertriglyceridemia. Nutrients. 2021; 13(2):552.
https://doi.org/10.3390/nu13020552
Chicago/Turabian Style
Esteve-Luque, Virginia, Ariadna Padró-Miquel, Marta Fanlo-Maresma, Emili Corbella, Xavier Corbella, Xavier Pintó, and Beatriz Candás-Estébanez.
2021. "Implication between Genetic Variants from APOA5 and ZPR1 and NAFLD Severity in Patients with Hypertriglyceridemia" Nutrients 13, no. 2: 552.
https://doi.org/10.3390/nu13020552
APA Style
Esteve-Luque, V., Padró-Miquel, A., Fanlo-Maresma, M., Corbella, E., Corbella, X., Pintó, X., & Candás-Estébanez, B.
(2021). Implication between Genetic Variants from APOA5 and ZPR1 and NAFLD Severity in Patients with Hypertriglyceridemia. Nutrients, 13(2), 552.
https://doi.org/10.3390/nu13020552